CN1938050A - 包含碘代单体以及二聚体混合物的x射线造影制剂 - Google Patents

包含碘代单体以及二聚体混合物的x射线造影制剂 Download PDF

Info

Publication number
CN1938050A
CN1938050A CNA2005800078749A CN200580007874A CN1938050A CN 1938050 A CN1938050 A CN 1938050A CN A2005800078749 A CNA2005800078749 A CN A2005800078749A CN 200580007874 A CN200580007874 A CN 200580007874A CN 1938050 A CN1938050 A CN 1938050A
Authority
CN
China
Prior art keywords
composition
independently
dimer
monomer
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2005800078749A
Other languages
English (en)
Chinese (zh)
Inventor
穆萨纳达·P·珀里亚撒米
布赖恩·D·多蒂
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mallinckrodt Inc
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Publication of CN1938050A publication Critical patent/CN1938050A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0438—Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CNA2005800078749A 2004-03-11 2005-03-11 包含碘代单体以及二聚体混合物的x射线造影制剂 Pending CN1938050A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55224004P 2004-03-11 2004-03-11
US60/552,240 2004-03-11

Publications (1)

Publication Number Publication Date
CN1938050A true CN1938050A (zh) 2007-03-28

Family

ID=34964357

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2005800078749A Pending CN1938050A (zh) 2004-03-11 2005-03-11 包含碘代单体以及二聚体混合物的x射线造影制剂

Country Status (12)

Country Link
US (1) US8679460B2 (enExample)
EP (2) EP1725268B1 (enExample)
JP (1) JP2007528424A (enExample)
KR (1) KR20070015517A (enExample)
CN (1) CN1938050A (enExample)
AT (1) ATE529135T1 (enExample)
AU (1) AU2005221716A1 (enExample)
CA (1) CA2559628A1 (enExample)
ES (1) ES2374633T3 (enExample)
IL (1) IL177888A0 (enExample)
NO (1) NO20064629L (enExample)
WO (1) WO2005087272A2 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11185598B2 (en) 2010-03-23 2021-11-30 Ge Healthcare As Preparation of stabilised x-ray diagnostic composition
CN120899953A (zh) * 2025-10-13 2025-11-07 浙江迪安鉴识科技有限公司 一种尸体用血管造影剂及其制备方法

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8445725B2 (en) * 2008-01-14 2013-05-21 Mallinckrodt Llc Process for the preparation of iosimenol
US11219696B2 (en) 2008-12-19 2022-01-11 Nationwide Children's Hospital Delivery of polynucleotides using recombinant AAV9
US20110256068A1 (en) * 2009-01-09 2011-10-20 Wistand Lars-Goeran Contrast media compositions
US20130039888A1 (en) 2011-06-08 2013-02-14 Nationwide Children's Hospital Inc. Products and methods for delivery of polynucleotides by adeno-associated virus for lysosomal storage disorders
JP2013091701A (ja) 2011-10-25 2013-05-16 Dow Corning Toray Co Ltd 硬化性組成物
US9725716B2 (en) * 2011-12-06 2017-08-08 Ohio State Innovation Foundation and Research Institute at Nationwide Children's Hospital Non-ionic, low osmolar contrast agents for delivery of antisense oligonucleotides and treatment of disease
CA2862495A1 (en) 2012-01-11 2013-07-18 Ge Healthcare As X-ray imaging contrast media with low iodine concentration and x-ray imaging process
HK1206939A1 (en) * 2012-05-30 2016-01-22 Verrow Pharmaceuticals, Inc. Stabilized formulations containing iodinated contrast agents and cyclodextrins
EP2879719B1 (en) 2012-08-01 2018-07-04 Nationwide Children's Hospital Intrathecal delivery of recombinant adeno-associated virus 9
KR102151088B1 (ko) * 2018-07-10 2020-09-02 한국원자력연구원 소체와 연결된 실 모양의 구조물 가시화 조성물 및 이의 가시화 방법
CN112386712B (zh) * 2020-11-09 2022-08-30 张洪 分子探针及其制备方法和用途
CN119656340A (zh) * 2024-12-13 2025-03-21 福安药业集团宁波天衡制药有限公司 一种碘佛醇注射液及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2511871A1 (fr) * 1981-08-28 1983-03-04 Guerbet Sa Procede pour augmenter la tolerance des produits opacifiants et produits opacifiants ainsi obtenus
US5698739A (en) 1989-07-05 1997-12-16 Schering Aktiengesellschaft Carboxamide non-ionic contrast media
CA2124559A1 (en) * 1991-12-03 1993-06-10 Mills Thomas Kneller Nonionic x-ray contrast agents, compositions and methods
IT1256248B (it) 1992-12-24 1995-11-29 Bracco Spa Formulazioni iniettabili acquose per radiodiagnostica comprendenti miscele di composti aromatici iodurati utili come agenti opacizzanti ai raggi x
DE19627309C2 (de) * 1996-06-27 1999-07-29 Schering Ag Wäßrige injizierbare Formulierungen verwendbar als Kontrastmittel
US8518373B2 (en) * 2001-08-03 2013-08-27 Bracco Imaging Spa Ionic and non-ionic radiographic contrast agents for use in combined X-ray and nuclear magnetic resonance diagnostics
ITMI20011706A1 (it) 2001-08-03 2003-02-03 Bracco Imaging Spa Agenti di contrasto radiografici ionici e non ionici, utilizzabili per l'indagine diagnostica combinata tramite raggi-x e risonanza magnetic
US7250153B2 (en) * 2002-12-12 2007-07-31 Biophysica Research, Inc. Contrast media formulations having improved biological tolerance

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11185598B2 (en) 2010-03-23 2021-11-30 Ge Healthcare As Preparation of stabilised x-ray diagnostic composition
CN120899953A (zh) * 2025-10-13 2025-11-07 浙江迪安鉴识科技有限公司 一种尸体用血管造影剂及其制备方法
CN120899953B (zh) * 2025-10-13 2025-12-12 浙江迪安鉴识科技有限公司 一种尸体用血管造影剂及其制备方法

Also Published As

Publication number Publication date
JP2007528424A (ja) 2007-10-11
AU2005221716A1 (en) 2005-09-22
CA2559628A1 (en) 2005-09-22
IL177888A0 (en) 2006-12-31
EP2253332A3 (en) 2011-03-23
US20080317675A1 (en) 2008-12-25
EP1725268B1 (en) 2011-10-19
EP1725268A2 (en) 2006-11-29
EP2253332A2 (en) 2010-11-24
US8679460B2 (en) 2014-03-25
ATE529135T1 (de) 2011-11-15
ES2374633T3 (es) 2012-02-20
KR20070015517A (ko) 2007-02-05
NO20064629L (no) 2006-11-28
EP2253332B1 (en) 2012-10-10
WO2005087272A2 (en) 2005-09-22
WO2005087272A3 (en) 2006-06-22

Similar Documents

Publication Publication Date Title
JP3585233B2 (ja) レントゲン撮影造影剤としてヨウ化芳香族化合物を使用する放射線診断用注射剤水溶液
AU637435B2 (en) X-ray contrast material for gastrointestinal tract
ES2486296T3 (es) Agentes de contraste
CN1938050A (zh) 包含碘代单体以及二聚体混合物的x射线造影制剂
Behrends-Steins et al. X-ray contrast media: overview, use and pharmaceutical aspects
JP2013133336A (ja) 高濃度の造影剤を含み高い造影増強効果を示す造影剤組成物
US20110256068A1 (en) Contrast media compositions
JP4310187B2 (ja) Ｘ線と核磁気共鳴との組み合わせ診断法で使用するためのイオン性及び非イオン性ｘ線写真造影剤
CA2509035C (en) Contrast media formulations having improved biological tolerance
US20070148096A1 (en) Contrast Agents
AU2014241494B2 (en) Method and reagent for preparing a diagnostic composition
JP2011500531A (ja) 造影剤
Aljohani Iodinated Contrast agents within Radiology
Jascinth et al. Contrast agents in computed tomography: A review
US7662859B2 (en) Contrast agents
GB2465663A (en) X-ray contrast agent compositions comprising an iodinated X-ray contrast agent and ethylenediamine-N,N-disuccinic acid
GB2457358A (en) X-Ray contrast agents comprising three iodinated phenyl groups
Parikh et al. Study of viscera by X-ray contrast media in diagnostic radiology
KR20150014526A (ko) 고농도의 조영제를 포함하여 높은 조영 증강 효과를 나타내는 조영제 조성물
Patil 38 Contrast Agents
Panchal Study of Viscera by X-Ray Contrast Media in Diagnostic Radiology
JP2012526733A (ja) ヨウ素を含む造影剤によって支援されたｘ線診断、特に、介入治療的ｘ線診断並びに放射線治療における、ヨウ素を含む単量体造影剤の高用量使用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
AD01 Patent right deemed abandoned

Effective date of abandoning: 20070328

C20 Patent right or utility model deemed to be abandoned or is abandoned